IHI ETF Analysis: U.S. Medical Devices | NYSE

Healthcare Equity | NYSE, USA | Market Cap: 4.025m USD | 12M Return: -5.5% | US4642888105 | Charts, Fundamentals & Technical Analysis

Imaging, Diagnostics, Prosthetics, Cardiac
Total Rating 39
Safety 59
Buy Signal 0.33
Healthcare Equity
Category Rotation: +2.5
TER: 0.42%
AUM: 4.03B
Avg Turnover: 193M
Risk 3d forecast
Volatility26.5%
VaR 5th Pctl4.72%
VaR vs Median-1.14%
Reward TTM
Sharpe Ratio-0.33
Rel. Str. IBD58.9
Rel. Str. Peer Group2.4 pctl
Character TTM
Beta0.376
Beta Downside0.474
Hurst Exponent0.489
Choppyness52.7%
Drawdowns 3y
Max DD26.64%
CAGR/Max DD0.28
CAGR/Mean DD0.99

Warnings

No concerns identified

Tailwinds

Supp Ema8

Seasonality 11.7 years of data

Jan +2.0% 9
Feb -0.9% 21
Mar -0.7% 27
Apr +0.5% 2
May -0.4% 10
Jun +1.1% 41
Jul +2.1% 5
Aug +0.6% 8
Sep -2.6% 59
Oct -1.2% 12
Nov +3.2% 43
Dec -0.1% 0

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: IHI U.S. Medical Devices

The iShares U.S. Medical Devices ETF (IHI) is a U.S.-listed exchange-traded fund that seeks to track the Dow Jones U.S. Select Medical Equipment Index, providing exposure to the medical equipment segment of the U.S. equity market. The underlying index includes manufacturers and distributors of non-disposable medical devices such as MRI scanners, pacemakers, X-ray machines, and prosthetics. IHI is classified as a non-diversified fund, concentrating its assets within a single industry sector rather than spreading them across multiple sectors.

Launched in May 2006, IHI falls within the health ETF category and is structured as a mid-cap fund. The medical device industry is characterized by high research and development costs and significant regulatory oversight, as devices sold in the U.S. generally require clearance or approval from the Food and Drug Administration before reaching the market. Companies in this space often generate revenue through a mix of capital equipment sales, recurring service contracts, and replacement parts.

Headlines to Watch Out For
  • Elective surgery volumes rise, boosting medical device revenue
  • FDA approvals accelerate for next-gen cardiac and robotic devices
  • GLP-1 drugs pressure demand for cardiac and bariatric devices
What is the price of IHI shares?

As of November 11, 2026, the stock is trading at USD 58.07 with a total of 1,462,670 shares traded. Over the past week, the price has changed by +2.91%, over one month by +10.00%, over three months by +4.89% and over the past year by -5.53%.

Current recommended Stop Loss: 56.30 (which is 3% or 1.3 ATR below the current price).

Is IHI a buy, sell or hold?

U.S. Medical Devices has no consensus analysts rating.